ISA247: Preliminary Phase IIb data

Preliminary data from an ongoing, open-label, U.S. and Canadian Phase IIb trial in 120 evaluable patients showed no transplant rejections in patients receiving

Read the full 237 word article

How to gain access

Continue reading with a
two-week free trial.